Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conservation of Small Populations02:04

Conservation of Small Populations

16.7K
Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
16.7K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

694
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
694
What is Population Genetics?01:25

What is Population Genetics?

64.5K
A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
64.5K
Population Growth00:57

Population Growth

28.1K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.1K
Relative Risk01:12

Relative Risk

2.0K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K
What are Populations and Communities?00:30

What are Populations and Communities?

37.4K
Overview
37.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study.

Urologic oncology·2017
Same author

Diagnostic Accuracy of <sup>64</sup>Copper Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Primary Lymph Node Staging of Intermediate- to High-risk Prostate Cancer: Our Preliminary Experience.

Urology·2017
Same author

The Microbiome of the Prostate Tumor Microenvironment.

European urology·2017
Same author

Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study.

Urologic oncology·2017
Same author

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer.

Clinical genitourinary cancer·2017
Same author

Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.

European urology·2017

Related Experiment Video

Updated: Jan 24, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K

Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.

Sebastiano Nazzani1, Felix Preisser2, Marco Bandini3

  • 1Cancer Prognostics and Health Outcomes Unit, Centre Hospitalier de l'Université de Montréal, Montreal, Canada; Academic Urology Department, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

European Urology Oncology
|May 18, 2019
PubMed
Summary
This summary is machine-generated.

Mortality from non-disease-specific causes is significant in surgically treated nonmetastatic retroperitoneal sarcoma (nmRPS). Patients with favorable tumor characteristics, like liposarcoma, often die from other causes, not their cancer.

Keywords:
Competing-risksLeiomyosarcomaLiposarcomaRadiotherapyRetroperitoneal SarcomaStandardized mortality ratio

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.8K
Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
03:42

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

1.1K

Related Experiment Videos

Last Updated: Jan 24, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.8K
Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
03:42

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

1.1K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Epidemiology

Background:

  • Limited data exist on non-disease-specific mortality (NDSM) versus disease-specific mortality (DSM) in surgically treated nonmetastatic retroperitoneal sarcoma (nmRPS).
  • Understanding these mortality causes is crucial for comprehensive patient management.

Purpose of the Study:

  • To investigate and compare the rates of NDSM and DSM in patients who underwent surgical treatment for nmRPS.
  • To identify factors influencing both NDSM and DSM in this patient cohort.

Main Methods:

  • Utilized the Surveillance, Epidemiology and End Results (SEER) database (2004-2014) for patient data.
  • Employed competing risks regression (CRR) methodologies to analyze 5-year mortality rates.
  • Multivariable CRR models assessed the impact of age, histologic subtype, grade, tumor size, and radiotherapy on NDSM and DSM.

Main Results:

  • Overall, 26.8% of patients died from DSM and 6.7% from NDSM.
  • Higher NDSM rates were observed in patients with age above median, liposarcoma, low grade, and larger tumors (≥17cm).
  • Higher DSM rates were associated with age above median, leiomyosarcoma, high grade, and larger tumors (≥17cm).
  • Age above median independently predicted higher NDSM (HR 1.7).
  • Specific subtypes (leiomyosarcoma, sarcoma not otherwise specified, other RPS), high grade, and larger tumors independently predicted higher DSM.

Conclusions:

  • NDSM significantly impacts outcomes in surgically treated nmRPS, especially in patients with favorable prognostic factors like liposarcoma and low-grade tumors.
  • Current predictors offer limited insight into NDSM, highlighting a need for further research.
  • This study underscores the importance of considering non-cancer-related mortality in the management of RPS.